Evidence map›Paper›PMID 30519791›Full record

ArticleEJNMMI research2018

Centiloid scaling for quantification of brain amyloid with [

Mark R Battle, Lovena Chedumbarum Pillay, Val J Lowe, David Knopman, Bradley Kemp, Christopher C Rowe, Vincent Doré, Victor L Villemagne, Christopher J Buckley

Abstract read
In one paragraph

Article in EJNMMI research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Association of cognitive impairment and APOE ε4 with Centiloids in Hispanic and non-Hispanic White cohorts.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Article
  6. Article
  7. Review
  8. Article
  9. Astrocyte reactivity across the AD continuum measured by [European journal of nuclear medicine and molecular imaging · 2026
    Article
  10. The clinical Alzheimer's disease spectrum classified in the A/T/N framework withEuropean journal of nuclear medicine and molecular imaging · 2026
    Observational
  11. Article
  12. Comparability of Centiloid values from [Neuroimage. Reports · 2026
    Article
  13. Article
  14. Article
  15. The Role of Amyloid-β and Tau PET in the New Era of Alzheimer Disease Therapies.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Review
  16. Article
  17. Exploring Centiloid Robustness: Impact of Sample Size and Image Resolution on Centiloid Conversion Accuracy.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mark R BattleImaging Technology Group, GE Healthcare, The Grove Centre, White Lion Road, Amersham, Buckinghamshire, UK.
Lovena Chedumbarum PillayImaging Technology Group, GE Healthcare, The Grove Centre, White Lion Road, Amersham, Buckinghamshire, UK.
Val J LoweMayo Clinic, Rochester, MN, USA.
David KnopmanMayo Clinic, Rochester, MN, USA.
Bradley KempMayo Clinic, Rochester, MN, USA.
Christopher C RoweAustin Health, Melbourne, Australia.
Vincent DoréAustin Health, Melbourne, Australia.
Victor L VillemagneAustin Health, Melbourne, Australia.
Christopher J BuckleyImaging Technology Group, GE Healthcare, The Grove Centre, White Lion Road, Amersham, Buckinghamshire, UK. christopher.buckley@ge.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionA standardised method for quantifying β-amyloid PET tracers would allow comparison across different tracers and different sites. The development of the Centiloid scale has aimed to achieve this, applying a common scale to better aid the diagnosis and prognosis of Alzheimer's disease (AD) and to monitor anti-amyloid therapeutic interventions. Here, we apply the Centiloid method to [

methodsPaired PiB and [

resultsThe standard uptake value ratios (SUVR), determined using the standard SPM8 Centiloid process, showed a strong correlation between [

conclusions[

Identifiers

PMID30519791
PMCPMC6281542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.